SCHEMBL30133444

SCHEMBL30133444

COc1cccc(Br)c1CBr

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
CA1 P00915 4/20 0.42
CA2 P00918 4/20 0.42
CA7 P43166 3/20 0.42
CA9 Q16790 3/20 0.42
CA12 O43570 2/20 0.42
CA14 Q9ULX7 2/20 0.42
CA4 P22748 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 5/20 0.39
HPGD P15428 4/20 0.39
L3MBTL1 Q9Y468 4/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
LMNA P02545 2/20 0.39
MAPK1 P28482 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6550705 1.00 HTR2A (0.43) HTR2AHTR2CCA1CA2CA7
SCHEMBL7802337 0.87 CA1 (0.50) HTR2AHTR2CCA1CA2CA7
SCHEMBL23499986 0.85 CA1 (0.44) HTR2AHTR2CCA1CA2CA7
SCHEMBL8342978 0.83 HTR2A (0.43) HTR2AHTR2CCA1CA2CA7
SCHEMBL27797008 0.82 HTR2A (0.42) HTR2AHTR2CCA1CA2CA7
SCHEMBL14879898 0.82 MAPT (0.42) HTR2AHTR2CCA1CA2CA7
SCHEMBL21768194 0.82 HTR2A (0.42) HTR2AHTR2CCA1CA2CA7
SCHEMBL2061829 0.81 NQO2 (0.39) HTR2AHTR2CCA2SMN1; SMN2MAPT
SCHEMBL19412338 0.80 ALDH1A1 (0.42) SMN1; SMN2MAPTHPGDL3MBTL1CYP1A2
SCHEMBL695730 0.79 CA1 (0.42) HTR2AHTR2CCA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119212994-A Pyrazolopyrazine compounds as SHP2 inhibitors 建新公司 2024-12-27 CN disclosed
CN-115605466-B Substituted oxoisoindoline compounds for the treatment of cancer 百时美施贵宝公司 2024-11-01 CN disclosed
EP-4448526-A1 PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS GENZYME CORPORATION (US) 2024-10-23 EP disclosed
CN-118359642-A Spiro aromatic ring compound and application thereof 上海奕拓医药科技有限责任公司 2024-07-19 CN disclosed
CN-111566104-B Spiro aromatic ring compound and application thereof 上海奕拓医药科技有限责任公司 2024-05-17 CN disclosed
CN-117143079-A Spiro aromatic ring compound and application thereof 上海奕拓医药科技有限责任公司 2023-12-01 CN disclosed
CN-111138412-B Spiro aromatic ring compound and application thereof 上海奕拓医药科技有限责任公司 2023-09-15 CN disclosed
WO-2023114954-A1 PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS GENZYME CORPORATION (US) 2023-06-22 WO disclosed
CN-115605466-A Substituted oxoisoindoline compounds for the treatment of cancer 百时美施贵宝公司(US) 2023-01-13 CN disclosed